Neuronetics (NASDAQ: STIM) reported Q3 EPS of ($0.44), $0.21 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $18.53 million versus the consensus estimate of $19.14 million.

GUIDANCE:

Neuronetics sees Q4 2024 revenue of $19-20 million, versus the consensus of $24.898 million.

Neuronetics sees FY2024 revenue of $71-72 million, versus the consensus of $77.919 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.